PrEP-001: Ph IIa PrEP-CS-003 data

The double-blind Phase IIa PrEP-CS-003 trial in 96 healthy volunteers showed that 6,400 µg PrEP-001 given 3 and 4 or 6 and 7 days before challenge with HRV-16 each missed the primary endpoint of impro...